Search Results - "Wiedmann, Lea A."

Evidence Quality and Health Technology Assessment Outcomes in Reappraisals of Drugs for Rare Diseases in Germany by Wiedmann, Lea A., Cairns, John A., Nolte, Ellen

“…Evidence on reappraisals of health technologies in Germany is limited, and for rare disease treatments (RDTs), the Federal Joint Committee follows different…”
Get full text

Evidence quality and health technology assessment outcomes in re-appraisals of drugs for rare diseases in Germany by Wiedmann, Lea A, Cairns, John A, Nolte, Ellen

“…Evidence on re-appraisals of health technologies in Germany is limited, and for rare disease treatments (RDTs) the Federal Joint Committee follows different…”
Get full text